Nli Holdings, Inc.
NL NYSE Industrial Inorganic Chemicals Financials FY2016βFY2025
What Nli Holdings, Inc. does
No business description yet.
- Legal name
- NLI HOLDINGS, INC.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Mar 9, 2026
- Accession Β· CIK
- 0001104659-26-025290
0000072162
Revenue and margins
Nli Holdings, Inc. had $158M of revenue in fiscal 2025, up 8.5% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was β$40.2M in fiscal 2025, β25.4% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Nli Holdings, Inc. returned $17.6M to shareholders in fiscal 2025. The diluted share count rose 0.0%.
Balance sheet
Cash, debt and the ratios that show how comfortably Nli Holdings, Inc. can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $147M | $139M | $165M | $163M | $111M |
| Interest coverage | 9.2x | 14.6x | 18.9x | 71.5x | 13.9x |
| Current ratio | 6.3x | 6.1x | 7.2x | 2.6x | 7.8x |
| Quick ratio | 5.5x | 5.1x | 6.2x | 2.3x | 6.3x |
| Total assets | $596M | $610M | $577M | $578M | $464M |
| Total liabilities | $234M | $228M | $207M | $181M | $105M |
| Shareholders' equity | $362M | $382M | $370M | $397M | $359M |
| Net debt (β = net cash) | β | β | β | β | β |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β | β | β | β | β |
| F-score | β / 3 | 4 / 8 | 4 / 8 | 6 / 8 | 4 / 8 | 6 / 8 | 3 / 8 | 5 / 8 | 3 / 8 | 4 / 8 |
| Accruals ratio | β3.2% | 20.8% | β10.6% | β0.3% | β0.8% | 5.9% | 1.1% | β6.6% | 7.2% | β0.3% |
| Altman Z'' | 3.35 | 4.27 | 2.75 | 4.30 | 4.67 | 5.17 | 5.26 | 5.79 | 6.18 | 7.45 |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $109M | $112M | $118M | $124M | $115M | $141M | $167M | $161M | $146M | $158M |
| Gross profit | $35.2M | $34.8M | $38.3M | $39.0M | $32.8M | $42.7M | $48.8M | $49.2M | $41.4M | $48.2M |
| Research and development | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Operating income | β$0.7M | $1.7M | β$60.7M | β$1.6M | $2.4M | $10.5M | $13.7M | $14.1M | $37.9M | $10.7M |
| Interest expense | $0.0M | $0.0M | $0.0M | $0.7M | $1.4M | $1.1M | $0.9M | $0.7M | $0.5M | $0.8M |
| Pretax income | $13.9M | $112M | β$54.4M | $28.6M | $13.6M | $60.8M | $39.2M | β$6.4M | $83.3M | β$51.4M |
| Income tax | β$2.8M | β$5.6M | β$15.4M | $0.6M | β$2.5M | $7.5M | $2.8M | β$7.0M | $14.1M | β$16.1M |
| Net income | $15.3M | $116M | β$41.0M | $25.8M | $14.7M | $51.2M | $33.8M | β$2.3M | $67.2M | β$37.8M |
| Diluted EPS | $0.31 | $2.38 | β$0.84 | $0.53 | $0.30 | $1.05 | $0.69 | β$0.05 | $1.38 | β$0.77 |
| Diluted shares | 0.05B | 0.05B | 0.05B | 0.05B | 0.05B | 0.05B | 0.05B | 0.05B | 0.05B | 0.05B |
| Cash flow | ||||||||||
| Cash from operations | $27.7M | $18.6M | $17.1M | $27.4M | $19.0M | $17.6M | $26.9M | $37.0M | $25.6M | β$36.4M |
| Capital expenditure | $3.2M | $2.8M | $3.1M | $3.2M | $1.7M | $4.1M | $3.7M | $1.1M | $1.4M | $3.7M |
| Free cash flow | $24.5M | $15.8M | $14.0M | $24.3M | $17.3M | $13.5M | $23.2M | $35.9M | $24.1M | β$40.2M |
| Depreciation and amortization | $3.8M | $3.7M | $3.5M | $3.7M | $3.8M | $3.8M | $4.0M | $4.0M | $3.7M | $3.7M |
| Dividends paid | β | $0.0M | $0.0M | $0.0M | $7.8M | $11.7M | $13.7M | $13.7M | $15.6M | $17.6M |
| Dividends and buybacks | β | $0.0M | $0.0M | $0.0M | $7.8M | $11.7M | $13.7M | $13.7M | $15.6M | $17.6M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $93.2M | $98.3M | $116M | $130M | $137M | $147M | $139M | $165M | $163M | $111M |
| Current assets | $123M | $131M | $167M | $165M | $171M | $194M | $194M | $218M | $238M | $160M |
| Current liabilities | $30.7M | $19.6M | $81.3M | $29.8M | $27.5M | $30.6M | $32.1M | $30.4M | $91.1M | $20.6M |
| Inventory | $15.0M | $15.4M | $17.1M | $18.3M | $18.3M | $25.6M | $31.3M | $30.7M | $28.4M | $30.4M |
| Property and equipment, net | $33.6M | $32.5M | $32.0M | $31.0M | $29.0M | $29.2M | $28.7M | $25.9M | $24.0M | $23.7M |
| Goodwill | $27.2M | $27.2M | $27.2M | $27.2M | $27.2M | $27.2M | $27.2M | $27.2M | $27.2M | $27.2M |
| Total assets | $385M | $552M | $547M | $557M | $548M | $596M | $610M | $577M | $578M | $464M |
| Total liabilities | $207M | $216M | $263M | $253M | $236M | $234M | $228M | $207M | $181M | $105M |
| Shareholders' equity | $178M | $335M | $284M | $305M | $312M | $362M | $382M | $370M | $397M | $359M |
| Margins | ||||||||||
| Gross margin | 32.3% | 31.1% | 32.4% | 31.4% | 28.7% | 30.4% | 29.3% | 30.5% | 28.3% | 30.4% |
| Operating margin | β0.7% | 1.5% | β51.3% | β1.3% | 2.1% | 7.5% | 8.2% | 8.8% | 26.0% | 6.7% |
| EBITDA margin | 2.8% | 4.8% | β48.4% | 1.7% | 5.4% | 10.2% | 10.6% | 11.2% | 28.5% | 9.1% |
| Net margin | 14.1% | 103.6% | β34.7% | 20.8% | 12.8% | 36.4% | 20.3% | β1.4% | 46.1% | β23.9% |
| FCF margin | 22.5% | 14.1% | 11.8% | 19.5% | 15.1% | 9.6% | 14.0% | 22.2% | 16.5% | β25.4% |
| Returns | ||||||||||
| Return on capital employed | β0.2% | 0.3% | β13.0% | β0.3% | 0.5% | 1.9% | 2.4% | 2.6% | 7.8% | 2.4% |
| Return on equity | 8.6% | 45.2% | β13.2% | 8.8% | 4.8% | 15.2% | 9.1% | β0.6% | 17.5% | β10.0% |
| Return on assets | 4.0% | 24.8% | β7.5% | 4.7% | 2.7% | 8.9% | 5.6% | β0.4% | 11.6% | β7.3% |
| Return on tangible equity | 10.2% | 37.7% | β16.0% | 9.3% | 5.2% | 15.3% | 9.5% | β0.7% | 18.2% | β11.4% |
| Growth | ||||||||||
| Revenue growth | β | 2.9% | 5.5% | 5.1% | β7.8% | 22.9% | 18.3% | β3.2% | β9.5% | 8.5% |
| Net income growth | β | 657.6% | β135.3% | β | β43.2% | 248.7% | β33.9% | β106.8% | β | β156.3% |
| EPS growth | β | 667.7% | β135.3% | β | β43.4% | 250.0% | β34.3% | β107.2% | β | β155.8% |
| FCF growth | β | β35.4% | β11.8% | 73.9% | β28.8% | β21.8% | 71.9% | 54.4% | β32.7% | β266.3% |
| Share count change | β | 0.0% | 0.0% | 0.0% | 0.1% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Financial health | ||||||||||
| Interest coverage | β178.8x | 56.6x | β1,639.6x | β2.4x | 1.7x | 9.2x | 14.6x | 18.9x | 71.5x | 13.9x |
| Current ratio | 4.0x | 6.7x | 2.0x | 5.5x | 6.2x | 6.3x | 6.1x | 7.2x | 2.6x | 7.8x |
| Quick ratio | 3.5x | 5.9x | 1.8x | 4.9x | 5.6x | 5.5x | 5.1x | 6.2x | 2.3x | 6.3x |
| Capital allocation | ||||||||||
| Capex / revenue | 2.9% | 2.5% | 2.6% | 2.5% | 1.5% | 2.9% | 2.2% | 0.7% | 1.0% | 2.4% |
| Payouts / FCF | β | 0.0% | 0.0% | 0.0% | 45.1% | 86.6% | 59.0% | 38.2% | 64.6% | β |
| Quality scores | ||||||||||
| Piotroski F-score | β | 4.0 | 4.0 | 6.0 | 4.0 | 6.0 | 3.0 | 5.0 | 3.0 | 4.0 |
| Altman Z'' | 3.4 | 4.3 | 2.8 | 4.3 | 4.7 | 5.2 | 5.3 | 5.8 | 6.2 | 7.4 |
| Accruals ratio | β3.2% | 20.8% | β10.6% | β0.3% | β0.8% | 5.9% | 1.1% | β6.6% | 7.2% | β0.3% |
Source: SEC EDGAR XBRL filings (CIK 0000072162). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.